ProShare Advisors LLC Buys 77,926 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

ProShare Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 460,247 shares of the medical equipment provider's stock after buying an additional 77,926 shares during the period. ProShare Advisors LLC owned approximately 0.13% of Intuitive Surgical worth $240,231,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $26,000. Parvin Asset Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Finally, Hurley Capital LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Stock Up 0.6%

Shares of Intuitive Surgical stock traded up $3.32 during trading on Friday, reaching $563.60. The company's stock had a trading volume of 1,422,176 shares, compared to its average volume of 1,644,552. The business's 50-day moving average price is $505.22 and its 200-day moving average price is $536.61. The firm has a market cap of $202.00 billion, a PE ratio of 87.93, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 52 week low of $395.60 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the business posted $1.50 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 188 shares of the company's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $566.94, for a total transaction of $106,584.72. Following the sale, the chief financial officer now directly owns 7,162 shares of the company's stock, valued at $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock valued at $16,865,621 over the last quarter. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.